MENU
+Compare
CATX
Stock ticker: ASE
AS OF
Dec 18, 04:59 PM (EDT)
Price
$2.96
Change
-$0.11 (-3.58%)
Capitalization
751.25M

CATX Perspective Therapeutics Forecast, Technical & Fundamental Analysis

a producer of therapeutic radioactive isotopes

CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for CATX with price predictions
Dec 17, 2024

CATX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on December 17, 2024

CATX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where CATX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for CATX just turned positive on December 06, 2024. Looking at past instances where CATX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CATX advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CATX as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for CATX moved below the 200-day moving average on November 14, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CATX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CATX entered a downward trend on December 04, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.990) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (70.423) is also within normal values, averaging (43.338).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CATX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CATX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CATX is expected to report earnings to rise 26.67% to -26 cents per share on March 27

Perspective Therapeutics CATX Stock Earnings Reports
Q4'24
Est.
$-0.27
Q3'24
Est.
$-0.21
Q2'24
Missed
by $0.16
Q1'24
Est.
$-0.02
Q4'23
Missed
by $0.03
The last earnings report on November 12 showed earnings per share of -20 cents, meeting the estimate of -20 cents. With 1.31M shares outstanding, the current market capitalization sits at 751.25M.
A.I. Advisor
published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSRKX24.81N/A
N/A
Northern Global Sustainability Index K
PMILX10.82-0.02
-0.18%
Putnam Multi-Asset Income R5
UBVLX87.62-1.07
-1.21%
Undiscovered Managers Behavioral Val L
OASVX13.51-0.18
-1.31%
Optimum Small-Mid Cap Value A
GCAVX21.72-0.33
-1.50%
GMO US Small Cap Value VI

CATX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
-11.78%
STRR - CATX
88%
Closely correlated
-2.02%
ANPCF - CATX
26%
Poorly correlated
N/A
DHR - CATX
26%
Poorly correlated
-0.28%
TMO - CATX
25%
Poorly correlated
-0.27%
BLFS - CATX
24%
Poorly correlated
-1.83%
More

Groups containing CATX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
-11.78%
CATX
(2 stocks)
97%
Closely correlated
-3.64%